Abstract
The genetic bases for antibiotic tolerance are obscure. Daptomycin (DAP) is a lipopeptide antibiotic with bactericidal activity against enterococci. Using time-kill assays, we provide evidence for the first time that a deletion of isoleucine in position 177 of LiaF, a member of the three-component regulatory system LiaFSR involved in the cell envelope response to antimicrobials, is directly responsible for a DAP-tolerant phenotype and is likely to negatively affect response to DAP therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 2831-2833 |
Number of pages | 3 |
Journal | Antimicrobial Agents and Chemotherapy |
Volume | 57 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2013 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases